Position in GILD
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$867,205,844
+$106,984,484 QoQ
Shares Held
6,222,328
+0.5% QoQ
Ownership
0.501%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 22.1041063730488.ToString("F0")%
Shared 1.7787715465979934.ToString("F0")%
None 76.11712208035321.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2020CallValue
$46,351
CallShares
620
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $16,087,469,920 across 16 Drug Manufacturers - General names. GILD ranks #7 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,435,647 | $3,528,649,542 | |
| 2 | LLY |
ELI LILLY & Co
|
3,547,772 | $3,263,134,246 | |
| 3 | AZN |
Astrazeneca PLC
|
12,129,724 | $2,392,224,162 | |
| 4 | ABBV |
AbbVie Inc.
|
9,531,362 | $2,072,975,912 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,540,774 | $1,508,529,698 | |
| 6 | PFE |
Pfizer Inc
|
31,428,987 | $882,525,946 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
6,222,328 | $867,205,844 | |
| 8 | AMGN |
Amgen Inc
|
2,255,759 | $793,688,795 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $867,205,844 | 6,222,328 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $760,221,360 | 6,193,754 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $994,037,079 | 8,955,289 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $685,291,785 | 6,181,039 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $746,953,531 | 6,666,252 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $696,174,024 | 7,536,798 | Shares | Sole | 2025-06-30 | |
| 2024-09-30 | $715,076,131 | 8,529,057 | Shares | Sole | 2025-06-26 | |
| 2024-06-30 | $494,472,401 | 7,207,002 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $549,401,951 | 7,500,368 | Shares | Sole | 2025-06-02 | |
| 2023-12-31 | $623,081,686 | 7,691,417 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $522,001,456 | 6,965,592 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $626,802,826 | 8,132,903 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $763,407,047 | 9,201,001 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $719,360,407 | 8,379,271 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $530,920,417 | 8,606,264 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $553,220,878 | 8,950,346 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $487,745,446 | 8,204,297 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $548,080,383 | 7,548,277 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $529,348,017 | 7,578,354 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $550,446,380 | 7,993,703 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $498,392,427 | 7,711,472 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $422,207,474 | 7,246,953 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $474,254,147 | 7,505,209 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $558,555,615 | 7,259,626 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $594,722,443 | 7,955,089 | Shares | Defined | 2020-05-14 | |
| 2020-03-31 | $46,351 | 620 | Call | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||